Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Mitochondrial Pathways
Lipo-C compounds combine lipotropic agents for fat metabolism support
The STEP TEENS trial (N=201, ages 12, 17) demonstrated that semaglutide 2.4 mg once weekly reduced BMI by 16.1% versus a 0.6% increase with placebo at 68 weeks [11]
5-Amino-1MQ and NAD+ are studied together to investigate combined NNMT inhibition and direct NAD+ supplementation effects on adipocyte metabolism and cellular energy pathways
AOD-9604 (Anti-Obesity Drug 9604) Description: A fat-burning peptide that stimulates the breakdown of stored fat while preventing new fat deposits, mimicking the fat-loss effects of growth hormone
